[{"NetIncomeLoss_1_Q2_USD":-23089000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":5251000.0,"OtherNoncashIncomeExpense_2_Q2_USD":98000.0,"LongTermDebt_0_Q2_USD":24500000.0,"OperatingLeaseExpense_2_Q2_USD":491000.0,"AssetsCurrent_0_Q2_USD":267108000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":172331.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1954000.0,"PaymentsToAcquireInvestments_2_Q2_USD":14907000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":101160000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":154000.0,"InterestPaidNet_2_Q2_USD":947000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":8896000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":7939000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":73000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2649221.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":732000.0,"AccruedSalariesCurrent_0_Q2_USD":6968000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2233000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":124654000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":36.03,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":424000.0,"ShareBasedCompensation_2_Q2_USD":5652000.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":-141000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":52000.0,"Assets_0_Q2_USD":271308000.0,"CommonStockSharesIssued_0_Q2_shares":26751091.0,"UnrecognizedTaxBenefits_0_Q2_USD":100000.0,"InventoryValuationReserves_0_Q2_USD":100000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":26289272.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":25227574.0,"GeneralAndAdministrativeExpense_2_Q2_USD":56033000.0,"LongTermNotesPayable_0_Q2_USD":24632000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":27000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"InterestPayableCurrent_0_Q2_USD":155000.0,"AccountsReceivableNetCurrent_0_Q2_USD":10235000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":81000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-4459000.0,"PrepaidExpenseCurrent_0_Q2_USD":4348000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":11000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":36.51,"ResearchAndDevelopmentExpense_1_Q2_USD":6062000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":3000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":375000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_0_Q2_USD":133806000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":127232000.0,"DepreciationAndAmortization_1_Q2_USD":200000.0,"DepreciationAndAmortization_2_Q2_USD":400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":13.79,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":3062000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-2905000.0,"Liabilities_0_Q2_USD":37714000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":116703000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":211237000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":639000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-23230000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-39282000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4131000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":2903000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":26981000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":33530000.0,"OperatingIncomeLoss_2_Q2_USD":-39254000.0,"InterestExpense_1_Q2_USD":526000.0,"InterestExpense_2_Q2_USD":1051000.0,"NonoperatingIncomeExpense_1_Q2_USD":-275000.0,"NonoperatingIncomeExpense_2_Q2_USD":-80000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":13042000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":211237000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_2_Q2_USD":18795000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-40026000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-23089000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-39334000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-141000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1380000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1070000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1519000.0,"InvestmentIncomeAmortizationOfDiscount_2_Q2_USD":88000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":478000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3307000.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGain_2_Q2_USD":100000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":9188000.0,"OperatingLeasePayments_1_Q2_USD":200000.0,"OperatingLeasePayments_2_Q2_USD":500000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1059000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":324995.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":233594000.0,"AdvertisingExpense_1_Q2_USD":5000000.0,"AdvertisingExpense_2_Q2_USD":11400000.0,"AdditionalPaidInCapital_0_Q2_USD":452891000.0,"GrossProfit_1_Q2_USD":10229000.0,"GrossProfit_2_Q2_USD":28279000.0,"AmortizationOfFinancingCosts_2_Q2_USD":110000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":12183000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":188377000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2903000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5652000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":12250000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":271308000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.67,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":33900000.0,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"InvestmentIncomeInterest_1_Q2_USD":248000.0,"InvestmentIncomeInterest_2_Q2_USD":890000.0,"InventoryNet_0_Q2_USD":9966000.0,"AccountsPayableTradeCurrent_0_Q2_USD":5103000.0,"OperatingIncomeLoss_1_Q2_USD":-22814000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":77.12,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":42279.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4687000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":338000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-219478000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1132084.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2649221.0,"LongTermInvestments_0_Q2_USD":0.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":34000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":636000.0,"StockholdersEquity_0_Q2_USD":233594000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":40000.0,"ProfitLoss_2_Q2_USD":-39334000.0,"ProfitLoss_1_Q2_USD":-23089000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.88,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.56,"InvestmentsAndOtherNoncurrentAssets_0_Q2_USD":469000.0,"OperatingExpenses_1_Q2_USD":33043000.0,"OperatingExpenses_2_Q2_USD":67533000.0,"CommonStockSharesOutstanding_0_Q2_shares":26751091.0,"ShortTermInvestments_0_Q2_USD":31322000.0,"Ticker":"INSP","CIK":"1609550","name":"INSPIRE MEDICAL SYSTEMS, INC.","OfficialName":"Inspire Medical Systems Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7075653659.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20200804"}]